LEO Pharma, specializing in medical dermatology and thrombosis, saw a 7% revenue increase in 2023, reaching €1.54 billion in net sales. In Spain, growth was 6.9%,...
Leo Pharma recorded a turnover of $1.44 billion (€1.34 billion) in 2021. The company has a strategic focus on drugs for skin diseases such as atopic...